Skip to content

Change and Clinical Significance of Plantar Fascia Thickness After ESWT

Change and Clinical Significance of Plantar Fascia Thickness After Extracorporeal Shock Wave Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00155324
Enrollment
60
Registered
2005-09-12
Start date
2004-10-31
Completion date
2006-07-31
Last updated
2012-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis

Keywords

plantar fasciitis, ultrasonographic examination

Brief summary

The aim of the study is to investigate the effect of extracorporeal shock wave therapy (ESWT) on the thickness of plantar fascia measured by ultrasonographic examination among patients with chronic plantar fascitis. The change of plantar fascia thickness will be correlated with clinical improvement.

Detailed description

The aim of the study is to investigate the effect of extracorporeal shock wave therapy (ESWT) on the thickness of plantar fascia measured by ultrasonographic examination among patients with chronic plantar fascitis. Two different dosage of ESWT will be applied, and the outcome will be followed 3 and 6 months after the treatment. The change of plantar fascia thickness will be correlated with clinical improvement, including the pain improvement, foot function, and quality of life at follow up.

Interventions

DEVICEExtracorporeal Shock Wave Therapy (Device)

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed as plantar fasciitis for at least 6 months * refractory to other conservative treatments

Exclusion criteria

* Acute infection of soft tissue/bone * Malignancy * Epiphysiolysis in the focus * Blood coagulation disorders * Pregnancy * Patients with pacemaker * Foot deformity * Autoimmune disorders-related arthropahy * Sciatica * Previous treatment with ESWT

Design outcomes

Primary

MeasureTime frame
Thickness of plantar fascia by ultrasonographic examination at 3 & 6 months

Secondary

MeasureTime frame
Foot function index at 3 & 6 months
Short Form-36 at 3 & 6 months
Pain (visual analogue scale) at 3 & 6 months

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026